Radical behaviorism

uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

Retrieved on: 
Thursday, December 16, 2021
HTT, Forward-looking statement, Putamen, Phase, Radical behaviorism, DSMB, Catheter, Șaeș, Chorea, Investor, CAG, Neuroscience, Huntington's disease, ALS, VG, Clinical trial, Doctor of Philosophy, Compte rendu, Brain, CNS, Conference, COVID-19, Spinocerebellar ataxia, Annual report, NASDAQ, Research, CSL Behring, Safety, Patient, Fabry disease, Disease, University of California, Dementia, Commercialization, Program, Haemophilia, Data monitoring committee, Neurodegeneration, University, Conference call, GLOBE, ID, Autosome, MRI, Central nervous system, Technology, AFL, Pharmaceutical industry, Medical imaging, Medical device

Two of the four enrolled patients received AMT-130, and two patients experienced an imitation (sham) surgery in this randomized, blinded clinical trial being conducted in the United States.

Key Points: 
  • Two of the four enrolled patients received AMT-130, and two patients experienced an imitation (sham) surgery in this randomized, blinded clinical trial being conducted in the United States.
  • NfL increased as expected immediately following the AMT-130 surgical procedure and returned to baseline in the two treated patients.
  • Nineteen patients have been enrolled in the clinical trial to date, including 9 of 16 in the higher-dose cohort.
  • The European, open-label Phase Ib/II study of AMT-130 will enroll 15 patients with early manifest Huntingtons disease across two dose cohorts.

The Scottish Medicines Consortium has accepted for use by NHS Scotland, Accord's Sixmo®▼ (buprenorphine implant) as a substitution treatment for opioid dependence in clinically stable adult patients

Accord, NHS, Skin, Factor X, Adult, Radical behaviorism, Marketing authorisation, NHS Scotland, Marketing, 2014 Amsterdam drug deaths, Drug, Healthcare Improvement Scotland, Prevalence, Disease, News, Brain, Health, SMC, Addiction, Patient, Pharmaceutical industry, Medical device, EU, Buprenorphine

LONDON, Dec. 13, 2021 /PRNewswire/ -- The Scottish Medicines Consortium has accepted for use by NHS Scotland, Accord's Sixmo (buprenorphine implant) as a substitution treatment for opioid dependence in clinically stable adult patients who meet the following criteria:

Key Points: 
  • LONDON, Dec. 13, 2021 /PRNewswire/ -- The Scottish Medicines Consortium has accepted for use by NHS Scotland, Accord's Sixmo (buprenorphine implant) as a substitution treatment for opioid dependence in clinically stable adult patients who meet the following criteria:
    Adult patients in Scotland with opioid dependence who are clinically stable and who require no more than 8mg/day of sublingual buprenorphine within a framework of medical, social and psychological treatment[1].
  • Yet treatment rates across Europe are low, with only around 50% of people with opioid dependence receiving some form of substitution treatment (2019).
  • The approval of Sixmo is excellent news for patients in Scotland."
  • Sixmo is delivered through an implant, placed under the skin by a trained physician, where it continuously releases buprenorphine into the body for a treatment cycle of six months.

New ManagedMethods Report Reveals 30% of K-12 School Districts Lack Cloud Application Security

Retrieved on: 
Tuesday, November 16, 2021
Cloud, Compliance, Safety, Google Workspace, 365, Privacy, Abuse, Student, Education, Self-harm, Technology, Research, Curriculum, API, Gaps, LMS, Cyberbullying, GLOBE, LGBTQ, Violence, School, Radical behaviorism, Risk, Microsoft, Medical device, Mobile phone, Management, Internet service provider, Demolition

The report reveals 30% of district administrators with at least a medium level of influence on technology decisions do not have a security platform to protect cloud applications.

Key Points: 
  • The report reveals 30% of district administrators with at least a medium level of influence on technology decisions do not have a security platform to protect cloud applications.
  • "School districts have long led the charge into cloud technology by embracing Google Workspace and Microsoft 365 cloud applications.
  • Among district administrators, cloud security, safety, and privacy are not a concern, despite schools being heavily reliant on cloud applications.
  • ManagedMethods is the leading Google Workspace and Microsoft 365 cybersecurity, student safety, and compliance platform for K-12 school districts.

AdminaHealth® Expands Technology Leadership Team

Retrieved on: 
Wednesday, November 10, 2021
University, Software as a service, Immaculata University, Southern New Hampshire University, Leadership, Organization, Worcester Polytechnic Institute, MBA, Insurance, Growth, Brandeis University, Multimedia, Software, TPA, Software engineering, Science, Product management, Solution, UnitedHealth Group, ITIL, Founding, Akamai Technologies, Radical behaviorism, Health insurance, Management

GREENWICH, Conn., Nov. 10, 2021 /PRNewswire/ --AdminaHealth, a leading provider of automated benefits billing solutions for the healthcare, insurance, and employee benefits marketplace, today announced the new addition of three key team members.

Key Points: 
  • GREENWICH, Conn., Nov. 10, 2021 /PRNewswire/ --AdminaHealth, a leading provider of automated benefits billing solutions for the healthcare, insurance, and employee benefits marketplace, today announced the new addition of three key team members.
  • As the number of customers and partnerships with top brokers, carriers, and TPAs increases, AdminaHealth is strengthening its leadership team to further accelerate innovation and expansion of their industry-recognized premium billing software.
  • "David, Amit, and Michelle are consummate leaders and creative innovators who we are excited to have join the AdminaHealth team furthering our position and ability to meet the demands for aggressive growth in 2022 and beyond."
  • For more information about the industry-recognized AdminaHealth Billing Suite SaaS technology platform and how you can automate your employee benefits invoice reconciliation and consolidation, visit AdminaHealth.com .

IBM to Expand Security Portfolio with Plans to Acquire ReaQta

Retrieved on: 
Tuesday, November 2, 2021
Cloud, Physical security information management, NDR, Company, Automation, Complexity, IBM Secure Service Container, Behavior, OS, Deep learning, Endpoint detection and response, Workflow, Twitter, Organization, General manager, Machine learning, NYSE, EDR, Risk, Intelligence, Connect, Investment, SOAR, CEO, Solution, XDR, Acquisition, Root cause analysis, Security information and event management, Radical behaviorism, IBM, Data breach, Security, SIEM, AI, Risk management, Cassette tape, Online shopping

ARMONK, N.Y., Nov. 2, 2021 /PRNewswire/ --IBM (NYSE: IBM) Security today announced an expansion of its cybersecurity threat detection and response capabilities with its plans to acquire ReaQta.

Key Points: 
  • ARMONK, N.Y., Nov. 2, 2021 /PRNewswire/ --IBM (NYSE: IBM) Security today announced an expansion of its cybersecurity threat detection and response capabilities with its plans to acquire ReaQta.
  • IBM's planned acquisition of ReaQta further differentiates the company's portfolio of connected, open security tools to unify and speed response to security threats.
  • ReaQta, whose primary business office is located in the Netherlands with headquarters in Singapore, will join the IBM Security business unit upon closing.
  • An evolution of the IBM QRadar security intelligence portfolio, IBM QRadar XDR is a suite of security software built on IBM's open, cloud-native security platform, Cloud Pak for Security.

uniQure Announces Latest Positive Recommendation from Data Safety Monitoring Board in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease

Retrieved on: 
Tuesday, November 2, 2021
Safety, Spinocerebellar ataxia, Fabry disease, Phase, Autosome, Haemophilia, Radical behaviorism, Technology, Huntington's disease, Disease, Neurodegeneration, Putamen, CNS, Patient, NASDAQ, Type III, Compte rendu, Data monitoring committee, Review, Brain, Annual report, Forward-looking statement, Risk, Clinical trial, COVID-19, CAG, Chorea, GLOBE, Central nervous system, DSMB, Dementia, Pharmaceutical industry

LEXINGTON, Mass. and AMSTERDAM, Nov. 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the positive recommendation by the independent Data Safety Monitoring Board (DSMB) following a review of safety data from the four patient procedures in the higher-dose cohort of the Phase I/II clinical trial of AMT-130 for the treatment of Huntington’s disease. With the positive recommendation, the final 12 patients in this second cohort are now cleared for enrollment.

Key Points: 
  • With the positive recommendation, the final 12 patients in this second cohort are now cleared for enrollment.
  • In the study to date, eight patients have been treated with AMT-130, and six patients have received imitation surgery.
  • The European, open-label Phase Ib/II study of AMT-130 will enroll 15 patients with early manifest Huntingtons disease across two dose cohorts.
  • Phase I/II or the European open-label Phase Ib/II clinical trials, , and whether we share initial imaging and biomarker data towards the end of the year or ever.

Senior Care Relocation & Transition Specialists are in High Demand

Retrieved on: 
Thursday, October 28, 2021
Risk, International Journal of Geriatric Psychiatry, Professional, Canadian International Council, Life, Certified Relocation and Transition Specialist, Compulsive hoarding, Certification, Hoarding, Falls, Radical behaviorism, Education, Medicine

With the combination of the baby boomer generation moving into their senior years and the global pandemic, which had an incredible effect on both the senior community and healthcare industry, it is no surprise that relocation and transition specialists are in high demand.

Key Points: 
  • With the combination of the baby boomer generation moving into their senior years and the global pandemic, which had an incredible effect on both the senior community and healthcare industry, it is no surprise that relocation and transition specialists are in high demand.
  • Organizing and downsizing can be an especially delicate transition because in many cases seniors have lived in their homes for decades and may have even developed hoarding behaviors.
  • This is why the Certified Relocation & Transition Specialist designation (CRTStm) was created.
  • This certification is more than education or trainingit is the most recognized symbol of professionalism and standards in move management, senior relocation, and senior transition services.

ManagedMethods Named Overall Enterprise Cloud Security Solution of the Year by the CyberSecurity Breakthrough Awards

Retrieved on: 
Thursday, September 30, 2021
Cloud, Computer, Self-harm, K-12, Google Meet, Violence, Microsoft, Risk management, Radical behaviorism, Cyberbullying, Google Workspace, Communal violence, LGBTQ, Data, Mobile security, 365, Safety, Email, Cloud computing security, Education, GLOBE, Medical device, Tutoring, Mobile phone

This award follows ManagedMethods' 2020 win in the Data Security Solution of the Year category and the Cloud Security Startup of the Year category in 2019.

Key Points: 
  • This award follows ManagedMethods' 2020 win in the Data Security Solution of the Year category and the Cloud Security Startup of the Year category in 2019.
  • "We're thrilled to be named a CyberSecurity Breakthrough Awards winner for the third year in a row," said Charlie Sander, Chief Executive Officer at ManagedMethods.
  • "Congratulations on being our choice this year for 'Overall Enterprise Cloud Security Solution of the Year.'"
  • These categories include Cloud Security, Threat Detection, Risk Management, Fraud Prevention, Mobile Security, Email Security and many more.

Red Hat Ansible Automation Platform 2 Drives Cloud-Native Automation and Helps Developers Become Automators

Retrieved on: 
Wednesday, September 29, 2021
Networks, Internet, Data Management, Technology, Software, Red Hat, Inc. v. SCO Group, Inc., Research, Efficiency, Red Hat, Solution, Culture, Gamesys, Human voice, Darwin (operating system), S&P Global, OpenShift, Automation, Environment, Radical behaviorism, Communication, Red, DevOps, Technology, Organization, Video game console, Sales, Mobile phone, Warehouse, Medical device

ANSIBLEFEST Red Hat, Inc., the world's leading provider of open source solutions, today announced Red Hat Ansible Automation Platform 2 as the companys new standard for hybrid cloud automation.

Key Points: 
  • ANSIBLEFEST Red Hat, Inc., the world's leading provider of open source solutions, today announced Red Hat Ansible Automation Platform 2 as the companys new standard for hybrid cloud automation.
  • Further addressing the need for automation at scale across the open hybrid cloud is automation mesh within Ansible Automation Platform.
  • The Red Hat Ansible Automation Platform Operator integrates Ansible Automation Platform directly with Red Hat OpenShift, enabling smoother cloud-native deployment of automation clusters, easier management and migration of data and platform performance upgrades further cementing automation into cloud-native processes.
  • The direction of Red Hat Ansible Automation Platform enables us to execute automation in containerized environments, supporting new strategies for innovation in the business.

Medical Solutions Welcomes Jorge Taborga as Chief Technology Officer

Retrieved on: 
Tuesday, September 28, 2021
Aureus, Texas A&M University, Partner (business rank), Joint Commission, Health, Saybrook University, Solution, Joint, Nursing, Engineering, PMO, Celebrity, Hospital, Texas, Carnegie Mellon University, Computer science, Omnicell, Acquisition, Company, Rising Medical Solutions, Growth, Leadership, Information technology, Technology, Architecture, Radical behaviorism, Organization, Presidio Graduate School, Travel, GLOBE, Risk management, Management, Medicine

Omaha, Neb., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Medical Solutions , one of the nations largest and fastest growing providers of total workforce solutions serving the healthcare industry, has announced the addition of Jorge Taborga as Chief Technology Officer.

Key Points: 
  • Omaha, Neb., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Medical Solutions , one of the nations largest and fastest growing providers of total workforce solutions serving the healthcare industry, has announced the addition of Jorge Taborga as Chief Technology Officer.
  • In his role at Medical Solutions, he oversees technology operations, including solutions architecture, applications development, analytics, PMO, security, and infrastructure.
  • "As Medical Solutions expands at a rapid pace, through acquisition and organic growth, diversifies our service offerings, and increases market share, the continued investment in product innovation and development, infrastructure, and new technologies are priorities for us, said Craig Meier, Chief Executive Officer, Medical Solutions.
  • "Im thrilled to join Medical Solutions at this transformational moment in the companys history, said Taborga.